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Abstract
A response to Struck MF. Infection control in burn patients: are fungal infections underestimated?
Scand J Trauma Resusc Emerg Med. 2009 Oct 9;17(1):51. [Epub ahead of print] PubMed PMID:
19818134.
Dr. Struck [1] appropriately points out the importance of
infecting agents apart from bacteria in the burn-injured
patient. Burn patients are frequently cited as having the
highest risk for invasive fungal infection as the burn
wound provides an ideal portal for invasive infection
while inducing immune dysfunction. Management of
large burns exposes patients to risks identified in other
patient groups including central venous lines, urinary
catheters, prolonged mechanical ventilation and broad-
spectrum antibiotics.
Unfortunately, it is difficult to determine the true inci-
dence and significance of fungal infections in the burn
population. Contamination of urine, respiratory tract and
skin by organisms such as Candida albicans is extremely
common. Criteria for identifying true infection in the set-
ting of burns remain unclear. Clinical findings, such as
fever, may not be discriminatory to help identify invasive
infection in burn patients. Specific definitions for burn/
wound infection rely heavily on wound appearance; fun-
gal infection, in contrast, is notoriously difficult to diag-
nose on clinical findings alone. At present, a wide variety
of practices exist among major North American burn cent-
ers to address this problem.
The American Burn Association recently published a review
of burn patients with positive fungal cultures [2]. In all,
positive cultures were seen in approximately 6% of 7,000
total admissions reviewed by reporting facilities. The inci-
dence of positive fungal cultures varied widely, ranging
from between 0.7% and 24% of patients treated at indi-
vidual burn centers. There was no consistent pattern of
treatment even if organisms were identified in the blood-
stream. The majority of positive cultures came from the
wound and respiratory tract (Figure 1).
When logistic regression was employed to examine factors
relating to mortality, age, burn size and inhalation injury
showed positive correlation. A positive culture of mold or
Aspergillus was also predictive of death. Each treated fun-
gal culture was associated with an increased hospital
length of stay by nearly eight days. Surprising in this data
was a high use of TPN, immunosuppressive agents and
the presence of malignancy. In summary, positive fungal
cultures are common in burns. Clinical significance must
be better defined. At present, there is no consistent indica-
tion for prophylaxis. Aggressive wound debridement and
avoidance of central venous catheters, parenteral nutri-
tion and other immunosuppressive agents as possible can
be recommended.
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In my practice, I will treat positive fungal blood cultures.
I will not treat positive sputum cultures unless a quantita-
tive threshold for pneumonia is reached. Finally, I do not
consider prophylaxis given the equivocal impact on mor-
tality unless a patient has multiple risk factors [3-5].
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